Web-Based Cognitive Behavioral Therapy Aids Bulimia Outcomes
By Lori Solomon HealthDay Reporter
THURSDAY, July 18, 2024 -- A web-based, cognitive behavioral self-help intervention effectively cuts bulimia nervosa symptoms, according to a study published online July 3 in JAMA Network Open.
Steffen Hartmann, from Heidelberg University in Germany, and colleagues evaluated the effectiveness of a web-based cognitive behavioral self-help intervention for individuals with bulimia nervosa. Adult patients with bulimia nervosa (154 participants; ages 19 to 65 years) were randomly assigned to 12 weekly modules or a wait-list control.
The researchers found that participants receiving the web-based intervention showed a significantly greater decrease in bulimic episodes versus the control group, representing a significant change in binge-eating episodes. However, there was no significant improvement seen in compensatory behaviors. Benefits of the intervention were also seen for improvement in global eating disorder symptoms and clinical impairment. Well-being and work capacity did not show improvement with the intervention.
"These findings underscore the effectiveness of web-based cognitive behavioral treatments for bulimia nervosa and suggest that these interventions can complement face-to-face therapies," the authors write. "Building on these results, future research should test whether more extensive interventions (i.e., blended or ecological momentary interventions) can impact compensatory behaviors, comorbid symptoms, and overall well-being more effectively."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Greater Neighborhood Disadvantage Tied to Inflammatory, Alzheimer Disease Biomarkers
THURSDAY, July 3, 2025 -- Greater neighborhood disadvantage is associated with increased inflammatory and Alzheimer disease (AD) cerebrospinal fluid (CSF) biomarkers in older...
Late-Life Mood Disorders May Indicate Predisposition to Dementia
MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...
Triglyceride-Glucose Index May Predict Faster Cognitive Decline in Early Phases of Alzheimer Disease
MONDAY, June 30, 2025 -- For patients with mild cognitive impairment (MCI) associated with Alzheimer disease (AD), those in the highest tertile of the triglyceride-glucose (TyG)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.